These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

706 related items for PubMed ID: 18717778

  • 21. Implementation of a strategy to prevent TRALI in a regional blood centre.
    Insunza A, Romon I, Gonzalez-Ponte ML, Hoyos A, Pastor JM, Iriondo A, Hermosa V.
    Transfus Med; 2004 Apr; 14(2):157-64. PubMed ID: 15113380
    [Abstract] [Full Text] [Related]

  • 22. Recipients of blood from a donor with multiple HLA antibodies: a lookback study of transfusion-related acute lung injury.
    Toy P, Hollis-Perry KM, Jun J, Nakagawa M.
    Transfusion; 2004 Dec; 44(12):1683-8. PubMed ID: 15584980
    [Abstract] [Full Text] [Related]

  • 23. Transfusion-related acute lung injury reports in the Netherlands: an observational study.
    van Stein D, Beckers EA, Sintnicolaas K, Porcelijn L, Danovic F, Wollersheim JA, Brand A, van Rhenen DJ.
    Transfusion; 2010 Jan; 50(1):213-20. PubMed ID: 19694998
    [Abstract] [Full Text] [Related]

  • 24. Transfusion related acute lung injury (TRALI) caused by red blood cell transfusion involving residual plasma anti-HLA antibodies: a report on two cases and general considerations.
    Odent-Malaure H, Quainon F, Ruyer-Dumontier P, Ducroz S, Verdier P, Voitellier E, Raynal MF, Fromont P, Muller JY, Rebibo D, Absi L, Garraud O.
    Clin Dev Immunol; 2005 Dec; 12(4):243-8. PubMed ID: 16584109
    [Abstract] [Full Text] [Related]

  • 25. Flow-cytometric approach to the prompt laboratory diagnosis of TRALI: a case report.
    Porretti L, Coluccio E, Prati D, Colombo MB, Lopa R, Tombolini P, Ambrosone A, Crespiatico L, Scalamogna M, Rebulla P.
    Eur J Haematol; 2004 Oct; 73(4):295-9. PubMed ID: 15347317
    [Abstract] [Full Text] [Related]

  • 26. Predicted effect of selectively testing female donors for HLA antibodies to mitigate transfusion-related acute lung injury risk from apheresis platelets.
    Eder AF, Dy BA, O'Neill EM.
    Transfusion; 2016 Jun; 56(6 Pt 2):1608-15. PubMed ID: 26830063
    [Abstract] [Full Text] [Related]

  • 27. Anti-leucocyte antibodies in platelet apheresis donors with and without prior immunizing events: implications for TRALI prevention.
    Sigle JP, Thierbach J, Infanti L, Muriset M, Hunziker G, Chassot K, Niederhauser C, Gowland P, Holbro A, Sunic K, Buser A, Fontana S.
    Vox Sang; 2013 Oct; 105(3):244-52. PubMed ID: 23773018
    [Abstract] [Full Text] [Related]

  • 28. White blood cell-reactive antibodies are undetectable in solvent/detergent plasma.
    Sachs UJ, Kauschat D, Bein G.
    Transfusion; 2005 Oct; 45(10):1628-31. PubMed ID: 16181214
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Acute and transient decrease in neutrophil count in transfusion-related acute lung injury: cases at one hospital.
    Nakagawa M, Toy P.
    Transfusion; 2004 Dec; 44(12):1689-94. PubMed ID: 15584981
    [Abstract] [Full Text] [Related]

  • 32. Relationship of donor HLA antibody strength to the development of transfusion-related acute lung injury.
    Hashimoto S, Nakajima F, Kamada H, Kawamura K, Satake M, Tadokoro K, Okazaki H.
    Transfusion; 2010 Dec; 50(12):2582-91. PubMed ID: 20667042
    [Abstract] [Full Text] [Related]

  • 33. Transfusion-related acute lung injury and leucocyte-reacting antibodies.
    Zupanska B, Uhrynowska M, Michur H, Maslanka K, Zajko M.
    Vox Sang; 2007 Jul; 93(1):70-7. PubMed ID: 17547568
    [Abstract] [Full Text] [Related]

  • 34. TRALI-new challenges for histocompatibility and immunogenetics in transfusion medicine.
    Flesch BK, Petershofen EK, Bux J.
    Tissue Antigens; 2011 Jul; 78(1):1-7. PubMed ID: 21658007
    [Abstract] [Full Text] [Related]

  • 35. Transfusion-related acute lung injury (TRALI): a case report and literature review.
    Donelan KJ, Anderson KA.
    S D Med; 2011 Mar; 64(3):85-8. PubMed ID: 21473518
    [Abstract] [Full Text] [Related]

  • 36. Transfusion-related acute lung injury prevention measures and their impact at Canadian Blood Services.
    Lin Y, Saw CL, Hannach B, Goldman M.
    Transfusion; 2012 Mar; 52(3):567-74. PubMed ID: 21895676
    [Abstract] [Full Text] [Related]

  • 37. Leucocyte antibodies in blood donors and a look back on recipients of their blood components.
    Maślanka K, Michur H, Zupańska B, Uhrynowska M, Nowak J.
    Vox Sang; 2007 Apr; 92(3):247-9. PubMed ID: 17348874
    [Abstract] [Full Text] [Related]

  • 38. Donor screening as a TRALI risk reduction strategy.
    Murphy MF, Navarrete C, Massey E.
    Transfusion; 2009 Sep; 49(9):1779-82. PubMed ID: 19735501
    [No Abstract] [Full Text] [Related]

  • 39. Transfusion-related acute lung injury (TRALI): a serious adverse event of blood transfusion.
    Bux J.
    Vox Sang; 2005 Jul; 89(1):1-10. PubMed ID: 15938734
    [Abstract] [Full Text] [Related]

  • 40. HLA class II antibodies in transfusion-related acute lung injury (TRALI). A case report.
    Lydaki E, Bolonaki E, Nikoloudi E, Chalkiadakis E, Iniotaki-Theodoraki A.
    Transfus Apher Sci; 2005 Oct; 33(2):107-11. PubMed ID: 16115801
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 36.